Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Martin Marietta Declares Quarterly Cash Dividend
-
Global Ship Lease Announces Fourth Quarter and Full Year 2025 Earnings Release, Conference Call and Webcast
-
KBR Dividend Declaration
-
AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results
-
Quanex Building Products Announces First Quarter 2026 Earnings Release and Conference Call Schedule
-
Burlington Stores, Inc. Announces Fourth Quarter and Fiscal Year 2025 Earnings Release Date, Conference Call and Webcast
-
DHT Holdings, Inc. secures one-year time charter for DHT Taiga
-
Compass Diversified Subsidiary The Honey Pot Co. Announces Appointment of Janis Smith-Gomez as Chair of the Board
-
Century Aluminum Company Reports Fourth Quarter 2025 Results
-
CTO Realty Growth Reports Fourth Quarter and Year End 2025 Operating Results
-
Vicor Corporation Reports Results for the Fourth Quarter and Year Ended December 31, 2025
-
Altus Group Reports Q4 & Fiscal 2025 Financial Results & Quarterly Dividend
-
QCR Holdings, Inc. Announces Increased Cash Dividend of $0.10 Per Share
-
Jakks Pacific Reports Fourth Quarter and Full-Year 2025 Financial Results
-
STRATA Skin Sciences Confirms Nasdaq Delisting
-
Inseego Reports Fourth Quarter and Full-Year 2025 Financial Results
-
NN, Inc. to Hold Fourth Quarter and Full Year 2025 Earnings Conference Call on Thursday, March 5, 2026
-
Candel Therapeutics Announces Proposed $100 Million Public Offering
-
Employers Holdings, Inc. Reports Fourth Quarter 2025 and Full-Year Financial Results; Declares Quarterly Cash Dividend of $0.32 per Share; and Announces Completion of $125 million Recapitalization Pla
-
Altus Group Reports Q4 & Fiscal 2025 Financial Results & Quarterly Dividend
-
LPL Financial Reports Monthly Activity for January 2026
-
MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program
-
WillScot Reports Fourth Quarter and Full Year 2025 Results and Provides 2026 Outlook
-
Nanox Expands in Latin America with Exclusive Nanox.ARC Distribution Agreement in Argentina
-
CarGurus Announces Fourth Quarter and Full-Year 2025 Results
-
EuroDry Ltd. Reports Results for the Quarter and Year Ended December 31, 2025
-
Q4 2025 Open House: Opendoor 2.0 Does What It Said It Would Do — Delivering Acquisition Growth, Faster Inventory Turns, and Stronger Cohorts
-
Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference
-
Digital Realty Declares Quarterly Cash Dividends for Common and Preferred Stock
-
ICU Medical Announces Fourth Quarter 2025 Results and Provides Fiscal Year 2026 Guidance
-
Wealthfront to Announce Fiscal Fourth Quarter and Full Year 2026 Financial Results on March 11, 2026
-
Casella Waste Systems, Inc. Announces Fourth Quarter and Fiscal Year 2025 Results and Provides Fiscal Year 2026 Guidance
-
Beta Bionics to Present at the TD Cowen 46th Annual Health Care Conference
-
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026
-
American Coastal Insurance Corporation Reports Financial Results for Its Fourth Quarter and Year Ended December 31, 2025
-
iRhythm Holdings Announces Fourth Quarter and Full Year 2025 Financial Results
-
Robinhood Markets, Inc. Reports January 2026 Operating Data
-
$HAREHOLDER ALERT: The M&A Class Action Firm Reminds $hareholders of Upcoming Merger Deadline—WBS, CCO, EWCZ, and RIG
-
Texas Roadhouse, Inc. Announces Fourth Quarter 2025 Results
-
Spyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
-
WillScot Declares Quarterly Cash Dividend
-
Akamai Reports Fourth Quarter 2025 and Full-Year 2025 Financial Results
-
Arhaus to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
-
Howard Hughes Holdings Inc. Reports Fourth Quarter and Full Year 2025 Results
-
Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
-
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
-
Galapagos Welcomes Dr. Paulo Fontoura to its Board of Directors
-
Candel Therapeutics Announces $100M Royalty Funding Agreement with RTW to Support the Potential Launch of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer
-
LegalZoom Reports Strong Fourth Quarter and Full Year 2025 Financial Results
-
Namib Minerals Regains Compliance with Nasdaq Listing Rules
